| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Sphingolipid metabolism in senescence 0.8380239355886655 2.869036870966186 0.0041172380015208 0.9182690445924508 0.2793902599925795 12 Q96G23,P16278,Q06136,Q13510,P04062 5 |
| Cholesterol biosynthesis with skeletal dysplasias 0.8993675929721685 2.4436280365637306 0.0145404091571179 0.9998623538454452 0.2810379403235825 6 Q16850,Q14739,Q15392,Q15125 4 |
| Photodynamic therapyinduced nfe2l2 nrf2 survival signaling 0.8982324131255287 2.4389631711470594 0.0147294693216233 0.9998774863647972 0.2810379403235825 6 P09601 1 |
| Glycosaminoglycan degradation 0.9498385206545426 2.416173668278452 0.0156845784657964 0.9999319992588788 0.2810379403235825 5 P06865,P16278,P54802 3 |
| Mitochondrial complex iv assembly 0.7677815162589005 2.401778334398521 0.0163155916954047 0.9999539252315834 0.2810379403235825 11 P00403,Q9Y2R0,P13073 3 |
| Sphingolipid pathway 0.8447227324584701 2.393954451378086 0.0166678185364892 0.999962927379549 0.2810379403235825 8 O15269,Q96G23,Q06136,Q13510,P04062 5 |
| Sphingolipid metabolism integrated pathway 0.8556539073582995 2.3727184725435895 0.0176577170034124 0.999979883957407 0.2820587952913516 7 O15269,Q96G23,Q06136,Q13510 4 |
| Sphingolipid metabolism overview 0.8556539073582995 2.3727184725435895 0.0176577170034124 0.999979883957407 0.2820587952913516 7 O15269,Q96G23,Q06136,Q13510 4 |
| Degradation pathway of sphingolipids including diseases 0.8528533144656228 2.3607917892638715 0.0182359659366682 0.9999859291382702 0.2838264441937846 7 P06865,P16278,P06280 3 |
| Cholesterol metabolism with bloch and kandutschrussell pathways 0.5908763626564006 2.192406343060386 0.028350179031986 0.999999973792028 0.3655575733271706 25 O00767,Q9UBM7,P48449,Q15800,Q15125,Q14739,Q15392,P35610,Q16850 9 |
| Oxidation by cytochrome p450 0.809306349469092 2.065553137655991 0.0388706932039726 0.9999999999646356 0.4537405918232958 6 P16435,Q16850,O43169 3 |
| Eicosanoid metabolism via lipooxygenases lox 0.8034632661237506 2.040469901812973 0.041303545856006 0.9999999999924064 0.4730424968791635 6 Q14914,O15254,Q8N8N7 3 |
| Statin inhibition of cholesterol production 0.8463286513446479 1.9996028150048917 0.0455431697380717 0.9999999999994847 0.4769909085093928 5 Q14534,Q8WTV0,P35610 3 |
| Metabolism of spingolipids in er and golgi apparatus 0.9262782401902478 1.9840445021886608 0.0472508790926315 0.9999999999998264 0.4769909085093928 3 Q06136,Q10472 2 |
| Familial partial lipodystrophy fpld 0.7645879865283537 1.976214738800232 0.0481304612921049 0.9999999999999007 0.4769909085093928 7 Q03252,P31751,O60725,O75844 4 |
| Eicosanoid metabolism via cyclooxygenases cox 0.7743454811020165 1.9144961290165547 0.0555567932732363 0.9999999999999992 0.4769909085093928 6 Q14914,O15254,Q8N8N7 3 |
| Nephrotic syndrome 0.5992280465655899 1.895032457525428 0.0580881017450209 0.9999999999999998 0.4769909085093928 15 P35579,O43707,Q14108,Q9NZC9,O75844 5 |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.598030362009143 1.887895889645978 0.0590399284712777 1.0 0.4769909085093928 15 P55209,P42167,P42166,P02545,O60725,P35222,P50402,O75844 8 |
| Ccl18 signaling pathway 0.6891028194091606 1.870743564326062 0.061380633355295 1.0 0.4769909085093928 10 Q86UE4,P00403,P19022,P08670 4 |
| Vitamin d metabolism 0.8852556480380471 1.8227476431483136 0.0683416208073794 1.0 0.4769909085093928 3 Q9UBM7,P04062 2 |
| Regulation of apoptosis by parathyroid hormonerelated protein 0.8815844778864037 1.808221732940617 0.0705719974564944 1.0 0.4769909085093928 3 Q9BXK5 1 |
| Primary focal segmental glomerulosclerosis fsgs 0.5525491655225648 1.7908031370561763 0.0733248916855815 1.0 0.4780249485686332 21 P46939,O43707,Q14108,P08670,Q9NZC9,P19022 6 |
| 7oxoc and 7betahc pathways 0.6442867924406309 1.7750066230165369 0.0758967936243419 1.0 0.4831820111297608 11 P34913,O15118,P61916,Q15125 4 |
| Ferroptosis 0.5353111081892815 1.7718613034873667 0.0764175833088254 1.0 0.4831820111297608 24 P09601,Q658P3,P02786,P45880,P16435 5 |
| Proteoglycan biosynthesis 0.8668252080856084 1.7496850727443534 0.0801726708625705 1.0 0.4915637496321243 3 Q8TB61,Q96L58 2 |
| Inclusion body myositis 0.8602726733242649 1.7236297018063005 0.0847747130299665 1.0 0.4991313203285898 3 P05067 1 |
| Iron metabolism in placenta 0.8591785992390341 1.7192754034441424 0.0855642364663862 1.0 0.4991313203285898 3 Q658P3 1 |
| Influence of laminopathies on wnt signaling 0.6576850514672525 1.7135818832902827 0.0866055431438022 1.0 0.4991313203285898 10 O60725,O75844 2 |
| Alzheimers disease and mirna effects 0.3924657355036635 1.6823909497261753 0.0924930551838432 1.0 0.5094880138515381 87 Q9NQC3,Q9NSK0,Q92542,P28070,P49721,P20618,P28072,P16615,P21796,O95197,P45880,Q96GC9,P28074,P05067,P31751 15 |
| Acquired partial lipodystrophy barraquersimons syndrome 0.8186973560461934 1.6537225220149203 0.0981839043906851 1.0 0.5094880138515381 4 Q03252,O60725 2 |
| Camkk2 pathway 0.5825674281332365 1.6495070580957445 0.0990437984093599 1.0 0.5094880138515381 13 P09601,O00429,O76024 3 |
| Omega3 omega6 fatty acid synthesis 0.7125415165792024 1.64203223607992 0.1005833236255138 1.0 0.510909755545929 6 O15254 1 |
| Nuclear receptors in lipid metabolism and toxicity 0.8879643387815754 1.623532172570077 0.1044756915994082 1.0 0.5208745535317684 2 P08183 1 |
| Electron transport chain oxphos system in mitochondria 0.4363113664122351 1.5775664048324736 0.1146652554192286 1.0 0.5208745535317684 43 O43676,P13073,Q9UDW1,P12235,P47985,P22695,O75964,P00403,P05141,P25705,P06576,P12236,P14406,P24539 14 |
| Alzheimers disease 0.3870767762459953 1.5671492577662811 0.117079807833889 1.0 0.5208745535317684 85 Q9NQC3,Q9NSK0,Q92542,P28070,P49721,P20618,P28072,P16615,P21796,O95197,P45880,P28074,P05067,P31751 14 |
| Nanomaterial induced apoptosis 0.7958006935002058 1.5614643165982962 0.1184142368702683 1.0 0.5208745535317684 4 O95831 1 |
| Mitochondrial complex iii assembly 0.6599476979246149 1.550961286161148 0.1209109618612198 1.0 0.5208745535317684 8 Q9UDW1,Q6DKK2,P47985 3 |
| Metapathway biotransformation phase i and ii 0.5020794582155333 1.5379073205183242 0.124071277134522 1.0 0.5208745535317684 24 Q99735,P34913,Q7LGA3,P07099,Q16850 5 |
| Constitutive androstane receptor pathway 0.7305852744773438 1.5139263079651215 0.1300445308458702 1.0 0.5208745535317684 5 P08183 1 |
| Endothelin pathways 0.6371516218055029 1.4953012071916052 0.1348358501857267 1.0 0.5293780309899118 9 P00403,P42892 2 |
| Copper homeostasis 0.6400715545275251 1.4561138955064656 0.1453611368797993 1.0 0.5446556178150507 8 P05067 1 |
| Vitamin a and carotenoid metabolism 0.7528640698723019 1.387505583019382 0.1652876498856517 1.0 0.5750549360625784 4 Q8WTV0 1 |
| Cohesin complex cornelia de lange syndrome 0.5099833556802305 1.3723825381205808 0.1699443831760023 1.0 0.5804607264333923 16 Q7Z5K2,P06493,P30154,Q29RF7,Q9UQE7,Q8N3U4 6 |
| Progeriaassociated lipodystrophy 0.567253781650865 1.3627239687705686 0.1729695208912263 1.0 0.5832916621165243 11 Q03252,Q14191,O60725,O75844 4 |
| Triacylglyceride synthesis 0.7660523186682489 1.3458327562499317 0.1783564589130379 1.0 0.5837127517565929 3 Q99943,O00116 2 |
| Nonalcoholic fatty liver disease 0.40593127183202 1.3377231954930435 0.1809866867651768 1.0 0.5837127517565929 48 O43676,P49840,Q9P0J0,P13073,Q9UDW1,P00403,Q96GC9,P14406,P31751 9 |
| Allograft rejection 0.5834183346197356 1.3331447921036306 0.1824842925479421 1.0 0.5837127517565929 10 P01889,P04439,P08183,P08670 4 |
| Hedgehog signaling pathway wp4249 0.7383337394709264 1.3284783798454405 0.1840201212887198 1.0 0.5837127517565929 4 Q2M1P5 1 |
| Ketogenesis and ketolysis 0.6228801925980753 1.326621207098885 0.1846340170300919 1.0 0.5837127517565929 7 O43772,P53985 2 |
| Nrf2 pathway 0.4753389402230035 1.317190610850541 0.1877747403326279 1.0 0.5866214663824999 23 P09601,Q14914,Q99735 3 |
| Sarscov2 and covid19 pathway 0.7329464042465977 1.3065881112711604 0.1913526364806177 1.0 0.5866214663824999 4 Q8WTV0 1 |
| Cell migration and invasion through p75ntr 0.6313977533727069 1.2760876374988772 0.2019245412054415 1.0 0.5883139586749185 6 Q9ULH0,P31751 2 |
| Cholesterol biosynthesis pathway 0.5184763697504452 1.2745990308600363 0.2024512006976584 1.0 0.5883139586749185 13 Q9UBM7,P48449,Q15800,Q16850 4 |
| 1q211 copy number variation syndrome 0.5916500099828247 1.2702696449781188 0.2039885969833981 1.0 0.5883139586749185 9 Q07157,Q86WJ1,Q13131,Q9NPH0,Q16625,P35222 6 |
| Nuclear receptors metapathway 0.3979832703917705 1.2615587326458624 0.2071076134479657 1.0 0.5883139586749185 49 P09601,O00767,Q15043,Q15067,P08183,Q99735,Q14914,P27105 8 |
| Relationship between inflammation cox2 and egfr 0.7164750657717872 1.2396784213208571 0.215094361638213 1.0 0.592638309687125 4 Q9H7Z7 1 |
| Vitamin d receptor pathway 0.5122805815433049 1.237851538119065 0.21577111440009 1.0 0.592638309687125 13 Q92604,Q96KA5,P08183 3 |
| Neural crest cell migration in cancer 0.5920510211201946 1.224768619220838 0.2206624116361384 1.0 0.5968054566821586 8 Q9ULH0,P31751 2 |
| S1p receptor signal transduction 0.5891173967290366 1.210565385161814 0.2260620173227596 1.0 0.6018802194538556 8 Q13510 1 |
| Striated muscle contraction pathway 0.6570802388677017 1.1986403151163711 0.2306678350021771 1.0 0.6026249236060732 5 P08670 1 |
| Liver x receptor pathway 0.7762258543833588 1.1581996312320753 0.2467825787944735 1.0 0.6235121278295941 2 O00767 1 |
| Estrogen receptor pathway 0.766419019316494 1.1178965951654427 0.2636111594062575 1.0 0.6349545013670052 2 Q15067 1 |
| Complement and coagulation cascades 0.7512630014858849 1.055982199229285 0.2909763475530544 1.0 0.6709448757088351 2 P49257 1 |
| Sterol regulatory elementbinding proteins srebp signaling 0.4152036201214305 1.0306106963240091 0.3027234180725775 1.0 0.6882139129964591 29 O00767,P48449,P49840,P42345,P37268,Q14534,Q8WTV0,Q16850 8 |
| Adipogenesis 0.4521870918989356 1.0017466506342068 0.3164659694251459 1.0 0.6998394351703364 16 O00767,P17096,P49327,P40763,P43490,P35222,P02545,O75844 8 |
| Interactions between loxl4 and oxidative stress pathway 0.6524462054311577 0.9813160449348772 0.3264369128211402 1.0 0.7044122206034595 4 Q9BQ95,Q8TAG9 2 |
| Complement system in neuronal development and plasticity 0.5325346317672919 0.9752356598588726 0.3294433772749094 1.0 0.7044122206034595 9 Q5KU26 1 |
| Type i collagen synthesis in the context of osteogenesis imperfecta 0.4806511919174101 0.9637894567284476 0.3351514936637647 1.0 0.7063783217149486 12 O75718,Q32P28 2 |
| Mammary gland development pathway involution stage 4 of 4 0.7170876671619622 0.9185533922962732 0.3583292197846366 1.0 0.7253941408471565 2 P40763 1 |
| Pregnane x receptor pathway 0.6366181383159197 0.918376135951284 0.3584219799084622 1.0 0.7253941408471565 4 P08183 1 |
| Synaptic vesicle pathway 0.4432262341180604 0.9129864980721224 0.3612496427333682 1.0 0.7253941408471565 14 Q00610,P50570,P12235,O00429,Q96CW1,P09496,Q9UQ16 7 |
| Neural crest cell migration during development 0.5339970300868941 0.9091052068023028 0.3632945944275709 1.0 0.7253941408471565 7 P31751 1 |
| Leptininsulin signaling overlap 0.7060921248142654 0.8751571266201323 0.3814884174174495 1.0 0.7372855608662557 2 P40763 1 |
| Regulation of wnt bcatenin signaling by small molecule compounds 0.6197388207520198 0.8519357958803346 0.3942497278767405 1.0 0.7549198259343265 4 P35222 1 |
| Insulin signaling in adipocytes normal condition 0.6162748576968671 0.8384034227951135 0.4018041677592721 1.0 0.7550932812070531 4 P31751 1 |
| Insulin signaling in adipocytes diabetic condition 0.6162748576968671 0.8384034227951135 0.4018041677592721 1.0 0.7550932812070531 4 P31751 1 |
| Proteasome degradation 0.360835065047066 0.8244701149147438 0.4096724897512587 1.0 0.7553083303173667 42 P04843,P28070,P46934,P49721,P20618,P28072,P01889,P28074 8 |
| Autosomal recessive osteopetrosis pathways 0.6912332838038643 0.8173010969041681 0.4137563800841928 1.0 0.7553083303173667 2 P51798 1 |
| Tyrobp causal network in microglia 0.5670476383145737 0.8162417175711097 0.4143619011461006 1.0 0.7553083303173667 5 Q5T1M5,P61916 2 |
| Nonhomologous end joining 0.5627005695203011 0.7982245584939827 0.4247401883160604 1.0 0.762238197707007 5 P12956 1 |
| Proximal tubule transport 0.5033516329550518 0.7965746517616363 0.4256981038264833 1.0 0.762238197707007 8 P05023,P11166,Q9UI12,P08183 4 |
| Oxysterols derived from cholesterol 0.4916739136817746 0.7726824301370528 0.439710347319151 1.0 0.7636719568447694 9 P34913,Q15125 2 |
| Caloric restriction and aging 0.5960803779459254 0.7603375900215258 0.4470528180798332 1.0 0.7636719568447694 4 P43490 1 |
| Arrhythmogenic right ventricular cardiomyopathy 0.425416020743349 0.7212951810245901 0.4707279212652309 1.0 0.7786300245226584 13 P16615,O43707,P50402,P19022 4 |
| Glucocorticoid receptor pathway 0.4918977515409621 0.7149855501422453 0.4746179721143058 1.0 0.7786300245226584 7 P27105 1 |
| Kennedy pathway from sphingolipids 0.5303423521689179 0.666512940355456 0.5050832952534057 1.0 0.7945297017011212 5 P35790,O95470 2 |
| Gastric cancer network 2 0.397931381789782 0.6538496786960453 0.5132086567222531 1.0 0.7987632170010452 16 Q86UE4,Q14739 2 |
| Apoptosisrelated network due to altered notch3 in ovarian cancer 0.3944035153476565 0.6315728295155077 0.5276660455167412 1.0 0.8072906630384551 16 P05067,P08670 2 |
| Rala downstream regulated genes 0.4852005086788648 0.6229502342327159 0.533317225499869 1.0 0.8072906630384551 6 P16989,Q8IYI6 2 |
| White fat cell differentiation 0.6374442793462123 0.6177230175426034 0.5367579365032631 1.0 0.8084666686289844 2 Q04726 1 |
| Monoamine transport 0.5489397306079267 0.5853510957960926 0.5583116646641442 1.0 0.8166148926533386 4 O15127 1 |
| Apoptosis modulation and signaling 0.3863229937843848 0.5808401322654038 0.5613482043749065 1.0 0.8170278951560305 16 O95831 1 |
| Ebola virus infection in host 0.3370351201308278 0.5487447355192482 0.5831806411041334 1.0 0.8270809559584321 40 Q08431,P42566,O43707,P61916,P46934,P12814,P10321,P01889,P20339,P09496,O15118,P04439,P35251,P41440,P46940 15 |
| Mitochondrial complex i assembly model oxphos system 0.3652588616073441 0.5257974361634108 0.5990289560910607 1.0 0.8385771010841944 23 Q9NPL8,O43676 2 |
| P53 transcriptional gene network 0.4402290127737708 0.5257507161393937 0.5990614210821112 1.0 0.8385771010841944 9 P04066,P49327,P11166,P43246 4 |
| Nocgmppkg mediated neuroprotection 0.4475748155592511 0.5190580622034844 0.6037202523456227 1.0 0.8385771010841944 7 Q99996 1 |
| H19 action rbe2f1 signaling and cdkbetacatenin activity 0.4570068432014403 0.5062435847841253 0.6126856615455016 1.0 0.8409444940222663 6 P35222,Q16527,P11802,Q15648,P06400 5 |
| Folate metabolism 0.3750466497220626 0.5026791138664127 0.6151898964458327 1.0 0.8409444940222663 15 Q8WTV0 1 |
| Amyotrophic lateral sclerosis als 0.4217651142869604 0.5002680718714012 0.616886332481819 1.0 0.8409444940222663 10 P07197,Q9BUN8 2 |
| 15q112 copy number variation syndrome 0.5203399846795242 0.4859926906772653 0.626972348314746 1.0 0.8416365683858287 4 Q7L576 1 |
| Hippo signaling regulation pathways 0.3730377088187339 0.484392012370074 0.6281076861264916 1.0 0.8416365683858287 14 Q13043,Q13131,P35222,P42345,P19022 5 |
| Hair follicle development organogenesis part 2 of 3 0.5356718192627713 0.4732973615483305 0.6360010442473167 1.0 0.8493761926756388 3 Q9BZE4,P35222 2 |
| Id signaling pathway 0.5353745541022487 0.4723425285110689 0.6366823190566979 1.0 0.8493761926756388 3 P28749,P24941 2 |
| Omega9 fatty acid synthesis 0.4438336513968408 0.4538793118949842 0.6499156946110056 1.0 0.8593704874511987 6 O00767,P49327 2 |
| Tryptophan metabolism 0.365595690149715 0.4409576905047964 0.6592436272714184 1.0 0.8594323469966099 14 P51648,Q15392 2 |
| Dna mismatch repair 0.3515122094495199 0.4185463418372838 0.6755477116942332 1.0 0.8635528335891496 22 Q9UQ84 1 |
| Splicing factor nova regulated synaptic proteins 0.3579422374145329 0.4070633228299171 0.6839614805273164 1.0 0.8667319805429666 16 Q15833,O14936,P20020,P19022 4 |
| Mbdnf and probdnf regulation of gaba neurotransmission 0.4243667940565528 0.3796081154881209 0.7042363357187607 1.0 0.885299276914275 6 Q13464,P40763,O95782 3 |
| Male infertility 0.3355893842932557 0.3600841928916974 0.7187841732880367 1.0 0.8861054175272104 26 P41440,Q15165,P08183 3 |
| Phosphoinositides metabolism 0.3842716711349527 0.3251461098031078 0.7450704926250358 1.0 0.8942678454155489 10 Q8TBX8,Q01968,Q13613,Q9Y217,O00443,Q9NTJ5,Q9C0I1,Q99570,P19174 9 |
| Gpcrs class a rhodopsinlike 0.5402674591381886 0.3185044493334396 0.7501023201713373 1.0 0.8945228061768207 2 Q9Y3P9 1 |
| Fluoropyrimidine activity 0.3431495391206 0.314237182057667 0.7533409046925046 1.0 0.8966233904869614 14 Q99808,P31350 2 |
| 3q29 copy number variation syndrome 0.3681221620852405 0.3038477772593123 0.7612438654584452 1.0 0.9007310454839692 11 P02786 1 |
| Glycerophospholipid biosynthetic pathway 0.3860313060210611 0.2875496600524342 0.7736914833866648 1.0 0.9119043309042826 9 Q86UL3,O95674,Q9BTU6,O00116,P48651 5 |
| Neural crest differentiation 0.3679623624897689 0.254428476951207 0.7991645532097802 1.0 0.925784978407744 10 Q9NR77 1 |
| Genes related to primary cilium development based on crispr 0.3494990621335926 0.2543891398948818 0.7991949401740657 1.0 0.925784978407744 12 Q10713,O95684,A0AVF1,Q9Y496 4 |
| Interleukin1 induced activation of nfkb 0.4533293697978536 0.2443859531202416 0.8069319198048417 1.0 0.9311932990903782 3 Q13501,P61088 2 |
| Mammalian disorder of sexual development 0.5013372956909379 0.2299440173645556 0.8181352717043338 1.0 0.9405456627358534 2 P35222 1 |
| Preimplantation embryo 0.3713760240861996 0.2249716896350642 0.8220012981425993 1.0 0.9432037579821508 8 P05023,P17096 2 |
| Pi3kaktmtor signaling pathway and therapeutic opportunities 0.426152071460037 0.215437242197604 0.8294264365577413 1.0 0.949517089061502 4 P42345 1 |
| Tgfbeta signaling in thyroid cells for epithelialmesenchymal transition 0.3934669190576442 0.200845604431082 0.8408193022506796 1.0 0.954102159847373 5 P08670 1 |
| Reninangiotensinaldosterone system raas 0.4304399524375596 0.1956275642293285 0.8449016839865213 1.0 0.954102159847373 3 Q13555,Q14012 2 |
| Angiopoietinlike protein 8 regulatory pathway 0.3038575452051803 0.1841542981076218 0.8538924110640682 1.0 0.9562964825016408 34 O00767,O75955,P11166,P49815,P49840,Q9UPT5,Q14254,Q13131,P49327,P41440,P42345,P31751 12 |
| Myd88 distinct inputoutput pathway 0.4531946508172378 0.1493950356819699 0.8812419287256938 1.0 0.9785470673073268 2 P61088 1 |
| Mitochondrial immune response to sarscov2 0.3479372163473226 0.1435542740746288 0.8858524505505183 1.0 0.9793704658058908 9 Q9Y276,Q9BQ95,Q86UT6 3 |
| Regulation of actin cytoskeleton 0.2938875075728368 0.1214706429944563 0.9033182659918696 1.0 0.9879534909136302 36 P35241,P35580,P12814,P26038,O00443,Q14185,O14974,Q9UQB8,Q13464,Q96F07,P46940,Q9UJX6 12 |
| Oxidative phosphorylation 0.2973367653170683 0.1001569768393523 0.9202197017120568 1.0 1.0 26 O75964,Q15904,Q86Y39,P25705,P24539 5 |
| Nipbl role in dna damage cornelia de lange syndrome 0.3597977995837097 0.0947928268523077 0.9244793845588504 1.0 1.0 4 Q13185,Q6KC79,P16104 3 |
| Prostaglandin and leukotriene metabolism in senescence 0.3589057389235872 0.0936026136578698 0.9254248333335716 1.0 1.0 4 P09960,Q96EB6,P06400 3 |
| Synaptic signaling pathways associated with autism spectrum disorder 0.3237061883017311 0.0858060464475976 0.931620599839079 1.0 1.0 10 P31751,P42345,Q13131 3 |
| Aryl hydrocarbon receptor pathway wp2873 0.3452274754683386 0.0767298858083156 0.938838429181561 1.0 1.0 4 Q16543,P07900,O00170 3 |
| Transcription cofactors ski and skil protein partners 0.3389830508474653 0.0698663759896609 0.9443000157800648 1.0 1.0 4 P51608,O14744,Q96ST3 3 |
| Microglia pathogen phagocytosis pathway 0.3249108204518384 0.0623013065770828 0.9503228880020488 1.0 1.0 3 O00443,P63000 2 |
| Follicle stimulating hormone fsh signaling pathway 0.3147070003955993 0.0618346647434333 0.9506944978220306 1.0 1.0 7 P42345,Q9UKG1 2 |
| Vitamin dsensitive calcium signaling in depression 0.3049687592978373 0.0443116868831831 0.9646559560402552 1.0 1.0 6 Q9Y4C1,O60341,P48506,P20020,P11413 5 |
| Immune response to tuberculosis 0.2844827586206824 0.0439974305267572 0.9649064520284678 1.0 1.0 3 P42224,O75925 2 |
| Mrna protein and metabolite inducation pathway by cyclosporin a 0.2594051473482891 0.0381738086180993 0.9695491033651942 1.0 1.0 3 P08195 1 |
| Map3k1 role in promoting and blocking gonadal determination 0.2767801301668863 0.0103738538309823 0.991723010649744 1.0 1.0 5 Q13464 1 |
| Development of ureteric collection system 0.2748290422484781 0.008932984141198 0.9928726046641938 1.0 1.0 5 O94813 1 |
|
|
